Gene · 8038
Papers1,979
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 1,979
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Aberrant AHRR, ADAMTS2 and FAM184 DNA Methylation: Candidate Biomarkers in the Oral Rinse of Heavy Smokers. | Biomedicines | 2023 | 37509437 | PubTator, text mining | PubMed |
| Validation of Immunotherapy Response Score as Predictive of Pan-solid Tumor Anti-PD-1/PD-L1 Benefit. | Cancer Res Commun | 2023 | 37497337 | PubTator, text mining | PubMed |
| ADAM12 expression is upregulated in cancer cells upon radiation and constitutes a prognostic factor in rectal cancer patients following radiotherapy. | Cancer Gene Ther | 2023 | 37495855 | PubTator, text mining | PubMed |
| Are the integrin binding motifs within SARS CoV-2 spike protein and MHC class II alleles playing the key role in COVID-19? | Front Immunol | 2023 | 37492575 | PubTator, text mining | PubMed |
| Severe udder cleft dermatitis lesion transcriptomics points to an impaired skin barrier, defective wound repair and a dysregulated inflammatory response as key elements in the pathogenesis. | PLoS One | 2023 | 37486897 | PubTator, text mining | PubMed |
| Hypoxia-based classification and prognostic signature for clinical management of hepatocellular carcinoma. | World J Surg Oncol | 2023 | 37481543 | PubTator, text mining | PubMed |
| Multi-omics in thoracic aortic aneurysm: the complex road to the simplification. | Cell Biosci | 2023 | 37475058 | PubTator, text mining | PubMed |
| Investigating the association between serum ADAM/ADAMTS levels and bone mineral density by mendelian randomization study. | BMC Genomics | 2023 | 37468870 | PubTator, text mining | PubMed |
| Cytogenomic Investigation of Syndromic Brazilian Patients with Differences of Sexual Development. | Diagnostics (Basel) | 2023 | 37443631 | PubTator, text mining | PubMed |
| A placental model of SARS-CoV-2 infection reveals ACE2-dependent susceptibility and differentiation impairment in syncytiotrophoblasts. | Nat Cell Biol | 2023 | 37443288 | PubTator, text mining | PubMed |
| ADAM12 promotes the resistance of lung adenocarcinoma cells to EGFR-TKI and regulates the immune microenvironment by activating PI3K/Akt/mTOR and RAS signaling pathways. | Int Immunopharmacol | 2023 | 37418984 | PubTator, text mining | PubMed |
| Glaucoma: Novel antifibrotic therapeutics for the trabecular meshwork. | Eur J Pharmacol | 2023 | 37391006 | PubTator, text mining | PubMed |
| Whole-genome and Epigenomic Landscapes of Malignant Gastrointestinal Stromal Tumors Harboring KIT Exon 11 557-558 Deletion Mutations. | Cancer Res Commun | 2023 | 37377752 | PubTator, text mining | PubMed |
| The Recent Research Progress of NF-κB Signaling on the Proliferation, Migration, Invasion, Immune Escape and Drug Resistance of Glioblastoma. | Int J Mol Sci | 2023 | 37373484 | PubTator, text mining | PubMed |
| Single-Cell Transcriptome Analysis Identifies Subclusters with Inflammatory Fibroblast Responses in Localized Scleroderma. | Int J Mol Sci | 2023 | 37372943 | PubTator, text mining | PubMed |
| A Silent Threat: Exploring the Impact of Endocrine Disruption on Human Health. | Int J Mol Sci | 2023 | 37372939 | PubTator, text mining | PubMed |
| Recent Advances in the Management of Clear Cell Renal Cell Carcinoma: Novel Biomarkers and Targeted Therapies. | Cancers (Basel) | 2023 | 37370817 | PubTator, text mining | PubMed |
| Tobacco exposure primes the secretion of CCL21 positively associated with tertiary lymphoid structure and response to immunotherapy. | J Immunother Cancer | 2023 | 37369391 | PubTator, text mining | PubMed |
| Network-Based Prediction of Side Effects of Repurposed Antihypertensive Sartans against COVID-19 via Proteome and Drug-Target Interactomes. | Proteomes | 2023 | 37368467 | PubTator, text mining | PubMed |
| PTK7 is a positive allosteric modulator of GPR133 signaling in glioblastoma. | Cell Rep | 2023 | 37354459 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8038/papers?page=10